FITZPATRICK LINDA A — SEC Form 4 filings
SEC reporting owner CIK 1188953. 9 Form 4 filings on record with FilingPulse; latest filed 2025-05-05.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-31 to 2025-05-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 37.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SUTRO BIOPHARMA, INC. (STRO) | CHIEF PEOPLE & COMM. OFFICER | 9 | — | — | 37 |
Form 4 filings — FITZPATRICK LINDA A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-05-05 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 9,125 @ $0 · Option exercise (M): 9,740 @ $0 · Option exercise (M): 13,140 @ $0 · Option exercise (M): 5,844 @ $0 · Tax withholding (F): 13,538 @ $1.07 · Option exercise (M): 9,125 (derivative) @ $0 · +3 more | EDGAR |
| 2025-03-07 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 8,750 @ $0 · Tax withholding (F): 3,594 @ $1.36 · Option exercise (M): 8,750 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 9,125 @ $0 · Tax withholding (F): 3,748 @ $1.42 · Option exercise (M): 9,125 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 6,875 @ $0 · Option exercise (M): 13,400 @ $0 · Tax withholding (F): 8,327 @ $1.59 · Option exercise (M): 6,875 (derivative) @ $0 · Option exercise (M): 13,400 (derivative) @ $0 | EDGAR |
| 2024-03-22 | 4/A | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 37,100 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 8,750 @ $0 · Tax withholding (F): 3,108 @ $4.54 · Grant/award (A): 38,000 (derivative) @ $0 · Grant/award (A): 28,500 (derivative) @ $0 · Option exercise (M): 8,750 (derivative) @ $0 · Grant/award (A): 22,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-03-06 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 9,125 @ $0 · Tax withholding (F): 3,739 @ $4.79 · Option exercise (M): 9,125 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 6,875 @ $0 · Tax withholding (F): 2,511 @ $4.95 · Option exercise (M): 6,875 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 8,250 @ $0 · Tax withholding (F): 3,380 @ $4.99 · Option exercise (M): 8,250 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1188953 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →